Implementing pathogen reduction technology while discontinuing blood donor deferral criteria for sexual risk behaviors: A simulation study
- 10 August 2024
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 64 (10) , 1949-1958
Abstract
Background: Combining pathogen reduction technology (PRT) with blood screening may alleviate concerns over the risk of transfusion‐transmitted infections (TTI) and support changes in blood donor selection to potentially increase blood availability. This study aimed to estimate the residual risk of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) transfusion‐transmission in Canada after implementing PRT, while eliminating deferrals for sexual risk behaviors.Study Design and Methods: A probabilistic approach that combined Bayesian networks with Monte Carlo simulations was used to estimate the risk of transfusing HIV‐, HBV‐, or HCV‐contaminated blood components. Different scenarios were considered to compare the current residual risk after PRT implementation, with and without donor deferral criteria for sexual risk behaviors. Donor profiles and blood component outcomes were simulated based on a literature review including the prevalence and incidence of HIV, HBV, and HCV in the Canadian blood donor population; the use of current blood screening assays; and HIV, HBV, and HCV blood donor viral loads.Results: In the universal PRT scenario (i.e., with PRT/without deferral criteria), the estimated risks of HIV, HBV, and HCV transmission were significantly lower than those in the currently observed scenario (i.e., without PRT/with deferral criteria).Conclusions: This risk model suggests that PRT for platelets and plasma (and eventually for RBCs when available) significantly reduces the residual risks of HIV, HBV and HCV transfusion‐transmission and could enable the removal of blood donor deferral criteria for sexual risk behaviors.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
This publication has 28 references indexed in Scilit:
- Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance dataTransfusion Clinique et Biologique, 2022
- Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2022
- Residual risk of HIV, HCV and HBV in CanadaTransfusion and Apheresis Science, 2017
- A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenariosTransfusion, 2017
- Defining “adequate” pathogen reduction performance for transfused blood componentsTransfusion, 2010
- Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusionTransfusion, 2009
- Assessing the impact of HBV NAT on window period reduction and residual riskJournal of Clinical Virology, 2006
- A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donorsTransfusion, 2005
- Occult hepatitis B virus infection: implications in transfusionVox Sanguinis, 2004
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003